Sansure Biotech Inc. (SHA:688289)

Sansure Biotech Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 22, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	11,581	13,001	11,187	12,747	23,600	45,580
Market Cap Growth	-10.17%	16.22%	-12.24%	-45.99%	-48.22%	-
Enterprise Value	8,768	8,982	6,408	7,417	18,716	41,873
Last Close Price	20.17	22.10	18.55	20.05	34.89	66.22
PE Ratio	50.05	47.17	30.76	6.58	10.52	17.42
Forward PE	34.58	8.19	8.19	8.19	12.20	13.61
PS Ratio	6.94	8.92	11.11	1.98	5.23	9.57
PB Ratio	1.60	1.77	1.51	1.70	3.70	9.61
P/TBV Ratio	1.98	1.88	1.62	1.72	3.73	9.67
P/FCF Ratio	-	-	-	6.37	15.69	17.99
P/OCF Ratio	57.92	47.37	256.93	4.98	12.57	17.25
EV/Sales Ratio	5.25	6.16	6.36	1.15	4.15	8.79
EV/EBITDA Ratio	29.72	33.53	80.30	3.27	7.28	13.52
EV/EBIT Ratio	75.89	70.58	-	3.38	7.41	13.64
EV/FCF Ratio	-40.80	-	-	3.71	12.44	16.53
Debt / Equity Ratio	0.15	0.06	0.01	0.00	0.00	0.01
Debt / EBITDA Ratio	3.74	1.53	0.40	0.01	0.01	0.02
Debt / FCF Ratio	-	-	-	0.01	0.01	0.02
Asset Turnover	0.19	0.17	0.11	0.79	0.72	1.56
Inventory Turnover	0.91	0.73	0.77	8.04	3.97	5.69
Quick Ratio	4.39	7.05	5.98	4.48	8.29	6.91
Current Ratio	4.88	7.67	6.47	4.79	8.99	7.38
Return on Equity (ROE)	3.09%	3.06%	4.66%	27.88%	40.31%	98.69%
Return on Assets (ROA)	0.80%	0.93%	-0.15%	16.86%	25.17%	62.94%
Return on Invested Capital (ROIC)	2.53%	3.86%	-0.78%	102.20%	186.47%	495.78%
Return on Capital Employed (ROCE)	1.40%	1.60%	-0.30%	28.90%	39.30%	64.40%
Earnings Yield	2.34%	2.12%	3.25%	15.19%	9.50%	5.74%
FCF Yield	-1.86%	-1.13%	-3.11%	15.69%	6.37%	5.56%
Dividend Yield	2.66%	2.38%	2.49%	6.47%	2.18%	1.15%
Payout Ratio	122.80%	97.39%	110.10%	33.92%	19.61%	11.51%
Buyback Yield / Dilution	-14.18%	0.05%	-0.26%	0.59%	-6.55%	-3.97%
Total Shareholder Return	-11.47%	2.42%	2.23%	7.07%	-4.37%	-2.82%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.